Research map: Urinary Biomarkers for Cancer Diagnosis and Surveillance: From Analytical Promise to Clinical Utility

Back to the article

Papers in this map

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews · Matthew James Page · 2021 · 106363 citations · Cited by this paper
  2. TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · 2026 · Related
  3. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods · Professor Gary S. Collins · 2024 · 3668 citations · Cited by this paper
  4. Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications · 2026 · Related
  5. SANRA—a scale for the quality assessment of narrative review articles · Christopher Baethge · 2019 · 2974 citations · Cited by this paper
  6. Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · 2026 · Related
  7. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors · Ibrahim Jubber · 2023 · 525 citations · Cited by this paper
  8. The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · 2026 · Related
  9. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges · Anna K. Füzéry · 2013 · 428 citations · Cited by this paper
  10. Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine · 2026 · Related
  11. Urine biomarkers in bladder cancer — current status and future perspectives · Moritz Maas · 2023 · 155 citations · Cited by this paper
  12. Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy · 2026 · Related
  13. Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles · Eline Oeyen · 2019 · 118 citations · Cited by this paper
  14. Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era · 2026 · Related
  15. Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis · Ekaterina Laukhtina · 2021 · 118 citations · Cited by this paper
  16. Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications · 2026 · Related
  17. Novel urinary biomarkers for the detection of bladder cancer: A systematic review · Wei Shen Tan · 2018 · 103 citations · Cited by this paper
  18. Liquid biopsy for early cancer detection in hereditary cancer syndromes: Current evidence · 2026 · Related
  19. Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome · Jouhyun Jeon · 2019 · 68 citations · Cited by this paper
  20. Current status and prospects of chemotherapy-free strategies in ovarian cancer · 2026 · Related
  21. Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery · Bongyong Lee · 2020 · 67 citations · Cited by this paper
  22. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer · Jeffrey J. Tosoian · 2024 · 64 citations · Cited by this paper
  23. Urinary markers for bladder cancer diagnosis: A review of current status and future challenges · Eisuke Tomiyama · 2023 · 61 citations · Cited by this paper
  24. Recent progress in mass spectrometry-based urinary proteomics · Neha S. Joshi · 2024 · 50 citations · Cited by this paper
  25. Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics · Joana Pinto · 2021 · 47 citations · Cited by this paper
  26. Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions · Felice Crocetto · 2025 · 43 citations · Cited by this paper
  27. Liquid Biopsy: Current advancements in clinical practice for bladder cancer · Felice Crocetto · 2025 · 35 citations · Cited by this paper
  28. Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD · Mona M. Khamis · 2018 · 33 citations · Cited by this paper
  29. Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis · Mariana Silva-Ferreira · 2024 · 32 citations · Cited by this paper
  30. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade · Thomas Hermanns · 2020 · 31 citations · Cited by this paper
  31. Liquid biopsy testing in urological cancers: Focus on urine · Pasquale Pisapia · 2025 · 27 citations · Cited by this paper
  32. Identification of the metabolic signatures of prostate cancer by mass spectrometry‐based plasma and urine metabolomics analysis · Chaowen Yu · 2021 · 23 citations · Cited by this paper
  33. A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial · Yair Lotan · 2024 · 22 citations · Cited by this paper
  34. Proteomic research and diagnosis in bladder cancer: state of the art review · Jorge L. Wilson · 2021 · 21 citations · Cited by this paper
  35. Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer · Hunter S. Robinson · 2024 · 21 citations · Cited by this paper
  36. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification · Sukhad Kural · 2024 · 17 citations · Cited by this paper
  37. Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients · Stephanie Jordaens · 2023 · 15 citations · Cited by this paper
  38. Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non–Digital Rectal Examination Urine · Jeffrey J. Tosoian · 2025 · 14 citations · Cited by this paper
  39. Emerging biomarkers in bladder cancer: Translating molecular advances into precision oncology · Matteo Ferro · 2025 · 14 citations · Cited by this paper

Source: OpenAlex (CC0)